Selective utilization of nonhomologous end-joining and homologous recombination DNA repair pathways during nervous system development

被引:152
|
作者
Orii, Kenji E.
Lee, Youngsoo
Kondo, Naomi
McKinnon, Peter J.
机构
[1] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA
[2] Gifu Univ, Sch Med, Dept Pediat, Gifu 5011194, Japan
关键词
ataxia telangiectasia mutated; DNA double strand-break; tumorigenesis; neurogenesis; genomic instability; STRAND BREAK REPAIR; LIGASE IV DEFICIENCY; CELL-CYCLE; DEFECTIVE NEUROGENESIS; GENOMIC STABILITY; ATM; DAMAGE; MICE; INTEGRITY; PROTEIN;
D O I
10.1073/pnas.0602436103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The repair of DNA double-strand breaks (DSBs) occurs via nonhomologous end-joining (NHEJ) or homologous recombination (HR). These mechanistically distinct pathways are critical for maintenance of genomic integrity and organismal survival. Although inactivation of either pathway leads to embryonic lethality, here we show selective requirements for each DNA DSB repair pathway at different stages of mammalian nervous system development. DNA damage-induced apoptosis resulting from inactivation of HR (Xrcc2 deficiency) only occurred in proliferating neural precursor cells, whereas disruption of NHEJ (DNA ligase IV deficiency) mainly affected differentiating cells at later developmental stages. Therefore, these data suggest that NHEJ is dispensable for a substantial portion of early development because DSB repair during this period utilizes HR. Moreover, DNA damage-induced apoptosis required the ataxia telangiectasia mutated (Atm) kinase after disruption of NHEJ, but not HR, during neurogenesis. However, embryonic lethality arising from disruption of either repair pathway was rescued by loss of p53 and resulted in specific tumor types reflective of the particular DSB repair pathway inactivated. Thus, these data reveal distinct tissue- and cell-type requirements for each DNA DSB repair pathway during neural development and provide insights for understanding the contributions of DNA DSB responses to disease.
引用
收藏
页码:10017 / 10022
页数:6
相关论文
共 50 条
  • [1] Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability
    Schwartz, M
    Zlotorynski, E
    Goldberg, M
    Ozeri, E
    Rahat, A
    le Sage, C
    Chen, BPC
    Chen, DJ
    Agami, R
    Kerem, B
    GENES & DEVELOPMENT, 2005, 19 (22) : 2715 - 2726
  • [2] Selective utilization of non-homologous end-joining and homologous recombination for DNA repair during meiotic maturation in mouse oocytes
    Lee, Crystal
    Leem, Jiyeon
    Oh, Jeong Su
    CELL PROLIFERATION, 2023, 56 (04)
  • [3] PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways
    Beck, Carole
    Boehler, Christian
    Barbat, Josee Guirouilh
    Bonnet, Marie-Elise
    Illuzzi, Giuditta
    Ronde, Philippe
    Gauthier, Laurent R.
    Magroun, Najat
    Rajendran, Anbazhagan
    Lopez, Bernard S.
    Scully, Ralph
    Boussin, Francois D.
    Schreiber, Valerie
    Dantzer, Francoise
    NUCLEIC ACIDS RESEARCH, 2014, 42 (09) : 5616 - 5632
  • [4] DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells
    Mao, Zhiyong
    Bozzella, Michael
    Seluanov, Andrei
    Gorbunova, Vera
    CELL CYCLE, 2008, 7 (18) : 2902 - 2906
  • [5] Alternative End-Joining and Classical Nonhomologous End-Joining Pathways Repair Different Types of Double-Strand Breaks during Class-Switch Recombination
    Cortizas, Elena M.
    Zahn, Astrid
    Hajjar, Maurice E.
    Patenaude, Anne-Marie
    Di Noia, Javier M.
    Verdun, Ramiro E.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (11): : 5751 - 5763
  • [6] Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways
    Ito, Soichiro S.
    Nakagawa, Yosuke
    Matsubayashi, Masaya
    Sakaguchi, Yoshihiko M.
    Kobashigawa, Shinko
    Matsui, Takeshi K.
    Nanaura, Hitoki
    Nakanishi, Mari
    Kitayoshi, Fumika
    Kikuchi, Sotaro
    Kajihara, Atsuhisa
    Tamaki, Shigehiro
    Sugie, Kazuma
    Kashino, Genro
    Takahashi, Akihisa
    Hasegawa, Masatoshi
    Mori, Eiichiro
    Kirita, Tadaaki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (37) : 12946 - 12961
  • [7] Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy
    Amrein, Lilian
    Davidson, David
    Shawi, May
    Petruccelli, Lucas A.
    Miller, Wilson H., Jr.
    Aloyz, Raquel
    Panasci, Lawrence
    LEUKEMIA RESEARCH, 2011, 35 (08) : 1080 - 1086
  • [8] DNA Repair by Homologous Recombination, But Not by Nonhomologous End Joining, Is Elevated in Breast Cancer Cells
    Mao, Zhiyong
    Jiang, Ying
    Liu, Xiang
    Seluanov, Andrei
    Gorbunova, Vera
    NEOPLASIA, 2009, 11 (07): : 683 - U83
  • [9] Alternative end-joining repair pathways are the ultimate backup for abrogated classical non-homologous end-joining and homologous recombination repair: Implications for the formation of chromosome translocations
    Iliakis, George
    Murmann, Tamara
    Soni, Aashish
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2015, 793 : 166 - 175
  • [10] Time-Dependent Predominance of Nonhomologous DNA End-Joining Pathways during Embryonic Development in Mice
    Chiruvella, Kishore K.
    Sebastian, Robin
    Sharma, Sheetal
    Karande, Anjali A.
    Choudhary, Bibha
    Raghavan, Sathees C.
    JOURNAL OF MOLECULAR BIOLOGY, 2012, 417 (03) : 197 - 211